Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

74.94
-1.1600-1.52%
Volume:3.30M
Turnover:242.90M
Market Cap:9.76B
PE:-127.37
High:75.48
Open:73.64
Low:70.94
Close:76.10
52wk High:102.81
52wk Low:11.16
Shares:130.29M
Float Shares:118.00M
Volume Ratio:1.01
T/O Rate:2.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5884
EPS(LYR):-0.3490
ROE:-9.40%
ROA:-5.05%
PB:11.83
PE(LYR):-214.70

Loading ...

10x Genomics Director Sarah A. Teichmann Disposes of USD 433,106 in Common Shares

Reuters
·
Aug 18

10x Genomics Director John R. Stuelpnagel Sells 20,000 Shares Worth $1.15 Million

Reuters
·
Aug 14

10x Genomics is Maintained at Overweight by Stephens & Co.

Dow Jones
·
Aug 13

10x Genomics (TXG) Gets a Buy from Stephens

TIPRANKS
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

10x Genomics, Inc. : Stephens Raises Target Price to $65 from $50

THOMSON REUTERS
·
Aug 12

Movement Alert|10x Genomics, Inc. Rises 5.09% in Regular Trading, Q2 Earnings Beat and Raised Full-Year Guidance Continue to Lift Shares

Market Focus
·
Aug 10

10x Genomics Inc : Canaccord Genuity Raises Target Price to $60 from $50

THOMSON REUTERS
·
Aug 10

10x Genomics price target raised to $47 from $42 at Piper Sandler

TIPRANKS
·
Aug 10

10x Genomics (TXG) Stock Rally Leans On Margin Gains And Cash

Simply Wall St.
·
Aug 08

10x Genomics is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Aug 08

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and 10x Genomics (TXG)

TIPRANKS
·
Aug 08

Movement Alert|10x Genomics, Inc. Rises 5.26% in Regular Trading, Q2 Earnings Beat Expectations and Full-Year Revenue Guidance Raised

Market Focus
·
Aug 07

Analysts Are Bullish on These Healthcare Stocks: Becton Dickinson (BDX), 10x Genomics (TXG)

TIPRANKS
·
Aug 07

Movement Alert|10x Genomics, Inc. Falls 5.7% in Pre-Market Trading, Q2 Revenue Declines 12.7% YoY as Company Swings to Loss

Market Focus
·
Aug 07

U.S. Research Roundup-Airbnb, Expedia Group, Parker-Hannifin

Reuters
·
Aug 07

Stock Track | 10x Genomics Plunges 5% in Post-Market as Q2 Revenue Declines and Swings to Loss

Stock Track
·
Aug 07

Stock Track | 10x Genomics Plunges 5.66% in After-hours as Q2 Revenue Declines 12.6% and Swings to Loss

Stock Track
·
Aug 07

10x Genomics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Movement Alert|10x Genomics, Inc. Falls 5.26% in After-Hours Trading, Q2 Revenue Drops 12.7% YoY with Swing to Loss

Market Focus
·
Aug 07